Literature DB >> 9225805

Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.

H Taniuchi1, Y Fujibayashi, Y Yonekura, J Konishi, A Yokoyama.   

Abstract

UNLABELLED: We evaluated the regional distribution of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM), a potential PET perfusion agent, in the rat brain and observed hyperfixation in transient global ischemia in rats.
METHODS: The distribution of 62Cu-PTSM was examined in comparison with that of 123I-labeled p-iodophenyl-N-isopropylmethanphetamine (123I-IMP) as a reference blood flow marker. Brain uptake of these two tracers was measured in Wistar rats subjected to 30-min four-vessel occlusion followed by recirculation for 10 min, 1 hr or 1, 3 or 5 days. Tracers were injected intravenously into rats 10 min before decapitation. The activities of Complex I and Complex I-III of mitochondria and the concentration of sulfhydryl (SH) groups were also measured.
RESULTS: Copper-62-PTSM showed accelerated accumulation in the brain at 1 hr and 1 day after reperfusion when compared with that of 123I-IMP (p < 0.01), and this enhancement was considered to be due to hyperfixation. At these time points, SH concentration was significantly decreased (p < 0.01). On the other hand, the activity of Complex I was not influenced by ischemia/reperfusion, but that of Complex I-III was decreased to 65-70% of the control level (p < 0.01).
CONCLUSIONS: Copper-62-PTSM showed hyperfixation most possibly as a result of increased NADH concentration, caused by disturbed electron transport in mitochondria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225805

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Authors:  J Lewis; R Laforest; T Buettner; S Song; Y Fujibayashi; J Connett; M Welch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Authors:  Mark P S Dunphy; Jason S Lewis
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

3.  Mitochondrials complex I activity is reduced in latent adriamycin-induced cardiomyopathy of rat.

Authors:  Kiyotaka Ohkura; Jong-Dae Lee; Hiromasa Shimizu; Akira Nakano; Hiroyasu Uzui; Motosaburo Horikoshi; Yasuhisa Fujibayashi; Yoshiharu Yonekura; Takanori Ueda
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.

Authors:  Paul D Bonnitcha; Amy L Vāvere; Jason S Lewis; Jonathan R Dilworth
Journal:  J Med Chem       Date:  2008-04-17       Impact factor: 7.446

5.  Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.

Authors:  Simone Alidori; Giancarlo Gioia Lobbia; Grazia Papini; Maura Pellei; Marina Porchia; Fiorenzo Refosco; Francesco Tisato; Jason S Lewis; Carlo Santini
Journal:  J Biol Inorg Chem       Date:  2007-11-27       Impact factor: 3.358

Review 6.  Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia.

Authors:  Kiran S Panickar; Richard A Anderson
Journal:  Int J Mol Sci       Date:  2011-11-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.